Home »
Academic Articles & Research Papers
Showing 20 of 27 academic articles
Cimmino L, Lopiano M, Tsekhovska V, Cimatti P et al. • Exploration of targeted anti-tumor therapy
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.37349/etat.2026.1002410
PMC: PMC13739404
Chen X, Ni P, Li W, Wu M et al. • Frontiers in immunology
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.3389/fimmu.2026.1958538
PMC: PMC13732141
Wang X, Wang Q, Gao W, He S et al. • Molecular cancer
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.1186/s12943-026-02748-w
PMC: PMC13556080
Zhao X, Wang H, Liu Y, Cao L • Frontiers in oncology
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.3389/fonc.2026.1919294
PMC: PMC13591093
Zheng S, Tan Z, Bao Y, Gong X et al. • Lipids in health and disease
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.1186/s12944-026-03011-3
PMC: PMC13599153
Zhong D, Li C, Xiao Z • Frontiers in immunology
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.3389/fimmu.2026.1938564
PMC: PMC13697605
Katja Niesel, Michael Schulz, Julian Anthes, Tijna Alekseeva et al. • EMBO Molecular Medicine
(2021)
Abstract The tumor microenvironment in brain metastases is characterized by high myeloid cell content associated with immune suppressive and cancer‐permissive functions. Moreover, brain metastases induce the recruitment of lymphocytes. Desp...
DOAJ
Open Access (DOAJ)
DOI: 10.15252/emmm.202013412
William Rodriguez, Ileana M. Cristea • Viruses
(2026)
Persistent oncovirus infections account for 15–20% of the global cancer burden, driving multiple forms of human cancer. To maintain persistent infection and spread, oncoviruses drive alterations in host cell metabolism, immune signaling, an...
DOAJ
Open Access (DOAJ)
DOI: 10.3390/v18030288
T. Malivanova, E. Skoromyslova, N. Mazurenko • EJC Supplements
(2015)
Tumor necrosis factor alpha (TNF) is a multifunctional cytokine, which possesses various biologic functions depending on the type of the cells and the physiological context. TNF is synthesized by immune cells as well as malignant cells. Acc...
DOAJ
Open Access (DOAJ)
DOI: 10.1016/j.ejcsup.2015.08.063
Shuping Wang, Pengcheng Chen, Xiaozhen Jing, Jinglin Zou et al. • Materials & Design
(2026)
STING agonist-based immunotherapy holds considerable promise for cancer treatment, yet its efficacy against immunologically “cold” tumors such as lung adenocarcinoma (LUAD) remains markedly limited. A major obstacle lies in the highly glyco...
DOAJ
Open Access (DOAJ)
DOI: 10.1016/j.matdes.2026.117182
Jing Ma, Ruijuan Ma, Xueke Zeng, Liming Zhang et al. • Journal of Experimental & Clinical Cancer Research
(2023)
Abstract Background Platinum-drugs based chemotherapy in clinic increases the potency of tumor cells to produce M2 macrophages, thus leading to poor anti-metastatic activity and immunosuppression. Lysosome metabolism is critical for cancer ...
DOAJ
Open Access (DOAJ)
DOI: 10.1186/s13046-023-02768-0
Yujun Cai, Gengjia Chen, Minzhao Lin, Bo Li et al. • Aggregate
(2024)
Abstract Nanodrugs capable of aggregating in the tumor microenvironment (TME) have demonstrated great efficiency in improving the therapeutic outcome. Among various approaches, the strategy utilizing electrostatic interaction as a driving f...
DOAJ
Open Access (DOAJ)
DOI: 10.1002/agt2.476
Choon Chiat Oh, Boon Yee Lim, Elizabeth Chun Yong Lee, Bavani Kannan et al. • JEADV Clinical Practice
(2025)
ABSTRACT Background Cutaneous squamous cell carcinoma (cSCC) remains poorly understood at the molecular level, both in the immunocompetent and immunosuppressed population with skin of colour. Data on the diversity of viruses found in cSCC i...
DOAJ
Open Access (DOAJ)
DOI: 10.1002/jvc2.70142
Xuanzhao Chen, Zeyan Li, Meihua Liang, Ziyang Zhang et al. • World Journal of Surgical Oncology
(2023)
Abstract Background Triple-negative breast cancer (TNBC) is the most heterogenous and aggressive subtype of breast cancer. Chemotherapy remains the standard treatment option for patients with TNBC owing to the unavailability of acceptable t...
DOAJ
Open Access (DOAJ)
DOI: 10.1186/s12957-023-03078-7
Patrick Leo, Hauke Kolster, Hartmut Koeppen, Jennifer Giltnane et al. • Journal of Pathology Informatics
(2026)
Whereas anti-PD-(L)1 therapies are widely used in cancer treatment, only a subset of patients achieve long-term survival. Companion diagnostics based on PD-L1 expression have limited predictive power for these therapies, motivating developm...
DOAJ
Open Access (DOAJ)
DOI: 10.1016/j.jpi.2026.100688
Xinbo Wang, Jiaying Miao, Sizhen Wang, Rongxi Shen et al. • Molecular Cancer
(2022)
Abstract Background Undifferentiated carcinoma with osteoclast-like giant cells (OGCs) of pancreas (UCOGCP) is a rare subtype of pancreatic ductal adenocarcinoma (PDAC), which had poorly described histopathological and clinical features. Me...
DOAJ
Open Access (DOAJ)
DOI: 10.1186/s12943-022-01596-8
Sophia Daum, Lilith Decristoforo, Mira Mousa, Stefan Salcher et al. • Molecular Cancer
(2025)
Abstract The dynamic interactions between tumor endothelial cells (TECs) and the immune microenvironment play a critical role in the progression of non-small cell lung cancer (NSCLC). In general, endothelial cells exhibit diverse immunomodu...
DOAJ
Open Access (DOAJ)
DOI: 10.1186/s12943-024-02221-6
Ziqiang Wang, Jing Zhang, Huili Chen, Xinyu Zhang et al. • Frontiers in Immunology
(2025)
BackgroundM2-like tumor-associated macrophages (TAMs) promote an immunosuppressive microenvironment and contribute to tumor progression and metastasis. However, their molecular characterization and prognostic value have not been fully explo...
DOAJ
Open Access (DOAJ)
DOI: 10.3389/fimmu.2025.1650726
Chun-Hua Wang, Lu-Kai Wang, Fu-Ming Tsai • Current Issues in Molecular Biology
(2025)
Tazarotene, a retinoid derivative, is widely used in treating skin conditions such as psoriasis and acne. Recent studies have demonstrated its potential as a promising therapeutic agent for treating melanoma in situ. Its primary mechanism o...
DOAJ
Open Access (DOAJ)
DOI: 10.3390/cimb47040237
Tessa Suzanne van Schooten, Sarah Derks, Elena Jiménez-Martí, Fatima Carneiro et al. • BMC Cancer
(2022)
Abstract Background Gastric Cancer (GC) is the fourth most deadly cancer worldwide. Enhanced understanding of its key epidemiological and molecular drivers is urgently needed to lower the incidence and improve outcomes. Furthermore, tumor b...
DOAJ
Open Access (DOAJ)
DOI: 10.1186/s12885-022-09689-9